Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026)
Aytu Biopharma (AYTU) posted quarterly Other Non-Current Assets of $556000.0 for Q1 2026, down 24.66% quarter-over-quarter from $738000.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Other Non-Current Assets for 14 consecutive years, with $556000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $556000.0; the TTM figure through Mar 2026 stood at $556000.0 (changed N/A YoY), while the FY2025 annual figure was $1.2 million, up 2636.36% from the prior year.
- Other Non-Current Assets eased to $556000.0 in Q1 2026 per AYTU's latest filing, from $738000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.5 million in Q2 2023 and bottomed at $44000.0 in Q2 2024.
- Historically, Other Non-Current Assets has averaged $905428.6 across 5 years, with a median of $825000.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets slumped 98.27% — and 2025, when it jumped 2636.36%.
- Aytu Biopharma's Other Non-Current Assets stood at $821000.0 in 2022, then advanced by 10.48% to $907000.0 in 2023, then plunged by 95.15% to $44000.0 in 2024, then jumped by 1577.27% to $738000.0 in 2025, then dropped by 24.66% to $556000.0 in 2026.
- Business Quant data shows AYTU's Other Non-Current Assets at $556000.0 in Q1 2026, $738000.0 in Q4 2025, and $939000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 13.00 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | 556,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 556,000.00 |
| Dec 31, 2025 | 738,000.00 |
| Sep 30, 2025 | 939,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 889,000.00 |
| Dec 31, 2023 | 907,000.00 |
| Sep 30, 2023 | 772,000.00 |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 892,000.00 |
| Dec 31, 2022 | 821,000.00 |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 766,000.00 |
| Mar 31, 2022 | 774,000.00 |
| Dec 31, 2021 | 457,000.00 |
| Sep 30, 2021 | 465,000.00 |
| Jun 30, 2021 | 465,000.00 |
| Dec 31, 2020 | 16,023.00 |
| Sep 30, 2020 | 16.02 Mn |
| Jun 30, 2020 | 33,000.00 |